Cardiac Pharmacology 2 (SUDWEEKS) Flashcards
All of the following are defects outside the heart that can potentially cause heart failure EXCEPT:
A. Coronary artery diseaes
B. Pulmonary hypertension
C. Diabetes
D. Valve deficiency
E. All of the above are defects outside of the heart
D. Valve deficiency
note: valve deficiency is another cause for heart failure but occurs within the heart
Which of the following is used to accelerate cardiac conduction in treating heart muscle failure?
A. Inotropic drugs
B. Chronotropic drugs
C. Dromotropic drugs
D. All of the above
E. None of the above
C. Dromotropic drugs
Inotropic = Force
Chromotropic = Rate
Dromotropic = Conduction velocity
Which of the following is used to increase heart rate?
A. Inotropic drugs
B. Chronotropic drugs
C. Dromotropic drugs
D. All of the above
E. None of the above
B. Chronotropic drugs
Inotropic = Force
Chromotropic = Rate
Dromotropic = Conduction velocity
Which of the following is used to increase the force of myocardial contraction?
A. Inotropic drugs
B. Chronotropic drugs
C. Dromotropic drugs
D. All of the above
E. None of the above
A. Inotropic drugs
Inotropic = Force
Chromotropic = Rate
Dromotropic = Conduction velocity
Beta-blockers:
A. Decrease heart rate
B. Decrease pressure
C. Decrease metabolic demand
D. C and D
E. All of the above
E. All of the above
Beta-blockers:
- decrease heart rate
- decrease pressure
- decrease metabolic demand
Diuretics:
- decrease pressure
- decrease metabolic demand
Vasodilators:
- decrease pressure
- decrease metabolic demand
Diuretics:
A. Decrease heart rate
B. Decrease pressure
C. Decrease metabolic demand
D. C and D
E. All of the above
D. C and D
Beta-blockers:
- decrease heart rate
- decrease pressure
- decrease metabolic demand
Diuretics:
- decrease pressure
- decrease metabolic demand
Vasodilators:
- decrease pressure
- decrease metabolic demand
Vasodilators:
A. Decrease heart rate
B. Decrease pressure
C. Decrease metabolic demand
D. C and D
E. All of the above
D. C and D
Beta-blockers:
- decrease heart rate
- decrease pressure
- decrease metabolic demand
Diuretics:
- decrease pressure
- decrease metabolic demand
Vasodilators:
- decrease pressure
- decrease metabolic demand
Beta-blockers work on which of the following receptors?
A. beta1
B. beta2
C. alpha1
D. alpha2
A. beta1
Beta-blockers = “olol”
note: Beta-blockers block sympathetic stimulation of the heart by working on the beta1 receptor. Beta1 receptors are associated with Epi and NE
What do Cardiac glycoside drugs treat and what are the 2 drugs we need to remember?
Congestive heart failure
- Digoxin and Digitalis
Which of the following is a cardiac glycoside used to treat congestive heart failure?
A. Digoxin
B. Tolvaptan
C. Ranolazine
D. Simvastatin
E. Fenofibrate
A. Digoxin
Cardiac glycoside = Digoxin and Digitalis
Which of the following is a cardiac glycoside used to treat congestive heart failure?
A. Simvastatin
B. Tolvaptan
C. Ranolazine
D. Digitalis
E. Fenofibrate
D. Digitalis
note: cardiac glycosides block the Na+/K+ ATPase
cardiac glycosides = Digoxin and Digitalis
Which of the following blocks the Na+/K+ ATPase?
A. Simvastatin
B. Tolvaptan
C. Ranolazine
D. Digitalis
E. Fenofibrate
D. Digitalis
Which of the following is used to block the Na+/K+ ATPase?
A. Beta-blockers
B. Cardiac glycosides
C. ACE inhibitors
D. ANG II blockers
B. Cardiac glycosides
Which of the following is used to treat congestive heart failure?
A. Beta-blockers
B. Cardiac glycosides
C. ACE inhibitors
D. ANG II blockers
B. Cardiac glycosides
All of the following are used to treat Acute heart failure EXCEPT:
A. Tolvaptan
B. Dopamine
C. Milrinone
D. Nesiritide
E. Ranolazine
E. Ranolazine
Acute heart failure tx:
- Dobutamine
- Dopamine
- Inamrinone, Milrinone, Vesnarinone
- Nesiritide
- Tolvaptan
All of the following are phosphodiesterase III inhibitors EXCEPT:
A. Inamrinone
B. Milrinone
C. Tolvaptan
D. Vesnarinone
E. All of the above are phosphodiesterase III inhibitors
C. Tolvaptan
note: phosphodiesterase III inhibitors all end in “rinone”
Which of the following is a catecholamine?
A. Dobutamine
B. Dopamine
C. Inamrinone
D. Nesiritide
E. Tolvaptan
B. Dopamine
Dobutamine = Beta1 agonist
Dopamine = catecholamine
Inamrinone = phosphodiesterase III inhibitor
Nesiritide = atrial natriuretic peptide agonist
Tolvaptan = vasopressin receptor antagonist
Which of the following is a Beta1 agonist?
A. Dobutamine
B. Dopamine
C. Inamrinone
D. Nesiritide
E. Tolvaptan
A. Dobutamine
Dobutamine = Beta1 agonist
Dopamine = catecholamine
Inamrinone = phosphodiesterase III inhibitor
Nesiritide = atrial natriuretic peptide agonist
Tolvaptan = vasopressin receptor antagonist
Which of the following is a vasopressin receptor antagonist?
A. Dobutamine
B. Dopamine
C. Inamrinone
D. Nesiritide
E. Tolvaptan
E. Tolvaptan
Dobutamine = Beta1 agonist
Dopamine = catecholamine
Inamrinone = phosphodiesterase III inhibitor
Nesiritide = atrial natriuretic peptide agonist
Tolvaptan = vasopressin receptor antagonist
Which of the following is a phosphodiesterase III inhibitor?
A. Dobutamine
B. Dopamine
C. Inamrinone
D. Nesiritide
E. Tolvaptan
C. Inamrinone
Dobutamine = Beta1 agonist
Dopamine = catecholamine
Inamrinone = phosphodiesterase III inhibitor
Nesiritide = atrial natriuretic peptide agonist
Tolvaptan = vasopressin receptor antagonist
Which of the followingm is an Atrial natriuretic peptide agonist?
A. Dobutamine
B. Dopamine
C. Inamrinone
D. Nesiritide
E. Tolvaptan
D. Nesiritide
Dobutamine = Beta1 agonist
Dopamine = catecholamine
Inamrinone = phosphodiesterase III inhibitor
Nesiritide = atrial natriuretic peptide agonist
Tolvaptan = vasopressin receptor antagonist
Antianginal drugs include all of the following EXCEPT:
A. Calcium channel blockers
B. Beta-blockers
C. ACE inhibitors
D. Vasodilators
E. Antiplatelet drugs
C. ACE inhibitors
Antianginal drugs:
- Ca2+ channel blockers
- Beta-blockers
- Vasodilators
- Antiplatelet drugs
- Lipid lowering drugs
Which of the following is antianginal drug that blocks late Na+ and KIR currents?
A. Ranolazine
B. Tolvaptan
C. Aspirin
D. Clopidogrel
E. Tirofiban
A. Ranolazine
Which of the following is an Antiplatelet drug that blocks the activation of platelets by inhibiting ADP receptor?
A. Ranolazine
B. Tolvaptan
C. Aspirin
D. Clopidogrel
E. Tirofiban
D. Clopidogrel
ADP receptor inhibitors = Clopidogrel and Prasugrel
Glycoprotein receptor inhibitors = Abciximab, Eptifibatide, Tirofiban
Blocks late Na+ and KIR currents = Ranolazine
Which of the following is an Antiplatelet drug that blocks platelet aggregation by inhibiting glycoprotein receptors?
A. Ranolazine
B. Tolvaptan
C. Aspirin
D. Clopidogrel
E. Tirofiban
E. Tirofiban
ADP receptor inhibitors = Clopidogrel and Prasugrel
Glycoprotein receptor inhibitors = Abciximab, Eptifibatide, Tirofiban
Blocks late Na+ and KIR currents = Ranolazine
Which of the following is an Antiplatelet drug that blocks platelet aggregation by inhibiting glycoprotein receptors?
A. Ranolazine
B. Abciximab
C. Aspirin
D. Clopidogrel
E. Tolvaptan
B. Abciximab
ADP receptor inhibitors = Clopidogrel and Prasugrel
Glycoprotein receptor inhibitors = Abciximab, Eptifibatide, Tirofiban
Blocks late Na+ and KIR currents = Ranolazine
All of the following are Antiplatelet drugs that is a GPIIb-IIIa glycoprotein receptor inhibitor EXCEPT:
A. Abciximad
B. Eptifibatide
C. Tirofiban
D. Tolvaptan
E. All of the above are glycoprotein receptor inhibitors
D. Tolvaptan
ADP receptor inhibitors = Clopidogrel and Prasugrel
Glycoprotein receptor inhibitors = Abciximab, Eptifibatide, Tirofiban
Blocks late Na+ and KIR currents = Ranolazine
All of the following are ADP receptor inhibitors EXCEPT:
A. Clopidogrel
B. Prasugrel
C. Ranolazine
D. All of the above are ADP receptor inhibitors
C. Ranolazine
ADP receptor inhibitors = Clopidogrel and Prasugrel
Glycoprotein receptor inhibitors = Abciximab, Eptifibatide, Tirofiban
Blocks late Na+ and KIR currents = Ranolazine
All of the following are true regarding Ranolazine EXCEPT:
A. prolongs ventricular AP
B. improves contractile dysfunction
C. blocks late Na+ KIR currents
D. All of the above are true
D. All of the above are true
Which of the following are used to treat high LDL levels?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. None of the above
A. Statins
Statins = high LDL
Fibrates = high VLDL
Which of the following are used to treat high VLDL levels?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. None of the above
B. Fibrates
Statins = high LDL
Fibrates = high VLDL
Which of the following is used to treat a patient with high LDL and VLDL levels?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. None of the above
C. Statins and Fibrates
Statins = high LDL
Fibrates = high VLDL
Which of the following types of dyslipidemia have elevated LDL only?
A. Type I dyslipidemia
B. Type IIa dyslipidemia
C. Type IIb dyslipidemia
D. Type III dyslipidemia
E. Type IV dyslipidemia
B. Type IIa dyslipidemia
Type IIa = LDL
Type IIb = LDL and VDL
Type III = VLDL
Type IV = VLDL
Which of the following types of dyslipidemia have elevated LDL and VLDL?
A. Type I dyslipidemia
B. Type IIa dyslipidemia
C. Type IIb dyslipidemia
D. Type III dyslipidemia
E. Type IV dyslipidemia
C. Type IIb dyslipidemia
Type IIa = LDL
Type IIb = LDL and VDL
Type III = VLDL
Type IV = VLDL
Which of the following types of dyslipidemia have elevated VLDL only?
A. Type I dyslipidemia
B. Type IIa dyslipidemia
C. Type IIb dyslipidemia
D. Type III dyslipidemia
E. Type IV dyslipidemia
D. Type III dyslipidemia
Type IIa = LDL
Type IIb = LDL and VDL
Type III = VLDL
Type IV = VLDL
Which of the following drugs is used to treat Type IIa dyslipidemia?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. none of the above
A. Statins
Statins = Type IIa
Statin and Fibrates = Type IIb
Fibrates = Type III, IV and V
Which of the following drugs is used to treat Type IIb dyslipidemia?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. none of the above
C. Statins and Fibrates
Statins = Type IIa
Statin and Fibrates = Type IIb
Fibrates = Type III, IV and V
Which of the following drugs is used to treat Type III dyslipidemia?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. none of the above
B. Fibrates
Statins = Type IIa
Statin and Fibrates = Type IIb
Fibrates = Type III, IV and V
Which of the following drugs is used to treat Type IV dyslipidemia?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. none of the above
B. Fibrates
Statins = Type IIa
Statin and Fibrates = Type IIb
Fibrates = Type III, IV and V
Which of the following drugs is used to treat Type V dyslipidemia?
A. Statins
B. Fibrates
C. Statins and Fibrates
D. none of the above
B. Fibrates
Statins = Type IIa
Statin and Fibrates = Type IIb
Fibrates = Type III, IV and V
Which of the following is an HMG-CoA reductase inhibitors?
A. Statins
B. Fibrates
C. Ezetimibe
D. Cholestyramine
A. Statins
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
Which of the following activate PPAR nuclear receptor?
A. Statins
B. Fibrates
C. Ezetimibe
D. Cholestyramine
B. Fibrates
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
Which of the following inhibits cholesterol absorption and is usually used as an adjunct with other drugs?
A. Statins
B. Fibrates
C. Ezetimibe
D. Cholestyramine
C. Ezetimibe
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
All of the following are Fibrates EXCEPT:
A. Clofibrate
B. Fenofibrate
C. Gemfibrozil
D. Cholestyramine
D. Cholestyramine
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
Which of the following are Bile Acid Sequestrants?
A. Clofibrate
B. Simvistatin
C. Gemfibrozil
D. Cholestyramine
D. Cholestyramine
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
All of the following are Bile Acid Sequestrants EXCEPT:
A. Cholestyramine
B. Colesevelam
C. Colestipol
D. Gemfibrozil
E. All of the above are Bile Acid Sequestrants
D. Gemfibrozil
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
All of the following are HMG-CoA reductase inhibitors EXCEPT:
A. Simvastatin
B. Lovastatin
C. Atorvastatin
D. Ezetimibe
E. All of the following are HMG-CoA reductase inhibitors
D. Ezetimibe
Statins = HMG-CoA reductase inhibitors
Fibrates = Clofibrate, Fenofibrate, Gemfibrozil
Ezetimibe = cholesterol absorption inhibitor
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
Which of the following has bulky resins that are unpalatable and often cause diarrhea?
A. Statins
B. Fibrates
C. Bile Acid Sequestrants
D. Cholesterol absorption inhibitors
C. Bile Acid Sequestrants
Bile Acid Sequestrants = Cholestyramine, Colesevelam, Colestipol
All of the following are true recarding Nicotinic Acid (Niacin) EXCEPT:
A. inhibits VLDL secretion
B. increases HDL
C. decreases LDL
D. decreases HDL
E. All of the above are true
D. decreases HDL
note: Nicotinic Acid (Niacin) is used as an adjunct when a statin is contraindicated (liver disease)
What do PCSK9 inhibitors do?
Inhibition of PCSK9 leadss to recycling of liver LDL receptors and removal of more cholesterol
(T/F)
Alirocuman and Evolocumab are newly approved drugs that are less safe to use than statins in patients with liver disease.
False
Correct statement: They are safer to use than statins on pts w/ liver disease.
note: Alirocumab and Evolocumab are monoclonal antibodies that are really expesive
Prophylactic antiobiotics are indicated in which of the following?
A. Previous myocardial infarction (heart attack)
B. Pts with cardiac pacemakers
C. History of endocarditis
D. Mitral valve prolapse
E. Previous coronary artery bypass surgery
C. History of endocarditis
Prophylactic antibiotics are contraindicated in:
- Previous myocardial infarction (heart attack)
- Pts with cardiac pacemakers
- Mitral valve prolapse
- Previous coronary artery bypass surgery
- innocent heart murmurs
What heart conditions are contraindications for use of prophylactic antibiotics? (pre-medicated before dental tx)
Premedication is contraindicated in:
- previous MI (heart attack)
- cardiac pacemakers
- mitral valve prolapse
- previous coronary artery bypass surgery
- innocent heart murmur
Discuss each of the following regarding prophylactic prevention of bacterial endocarditis:
- Standard regimen
- Penicillin allergy
- IV or IM medications for pts who can’t take medication orally
- What antibiotic has a 10% risk of cross-allergy with penicillin?
Prophylaxis
Standard regimen: amoxicillin
Penicillin allergy: Clindamycin, cephalexin and azithromycin
IM or IV medications: Cefazolin, Ceftriaxone or Ampicillin
- Cephalasporins have a 10% risk of cross-allergy with penicillin
What are the indications for Prophylaxis before a dental appt?
Indications for Prophylaxis:
- heart valve surgery
- hx of endocarditis
- heart transplant
- cyanotic congenital heart disease
What are the two medications that are PCSK9 inhibitors?
Alicrocumab, Evolocumab